PTEN and cancer: Although the partial loss of PTEN determines an increases in proliferation, its biallelic inactivation, prevalent in advanced stages of cancers [4,5,164,165], leads to cellular senescence, a protective mechanism to restrict tumorigenesis that is dependent on p53 and may follow mTORC1-mediated increased translation and stabilization [164,166].